Skip to main content

Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About
Trending Topics
    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Entertainment & Media
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor, Employment, and Benefits
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations
    Industries

    View All

    • Aviation
    • Cannabis
    • Consumer
    • Energy
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Nonprofit Organizations
    • Real Estate
    • Sports & Stadiums
    • Technology
    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Environmental, Social, and Governance (ESG)

      We help clients create positive return on investments in people, products, and the planet.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    • Women in Dealmaking

      We provide strategic counsel on complex corporate transactions and unite dynamic women in the dealmaking arena.

    1. Home
    2. Insights
    3. Alerts
    4. Antitrust implications of COVID-19: The DOJ and FTC react to the pandemic

      Alerts

    Alert / Antitrust

    Antitrust implications of COVID-19: The DOJ and FTC react to the pandemic

    March 18, 2020

    LinkedInX (Twitter)EmailCopy URL

    By Brian Whittaker and Gordon Lang

    The US Department of Justice and Federal Trade Commission react to the COVID-19 pandemic.

    DOWNLOAD

    The DOJ and FTC react to the COVID-19 pandemic (PDF)

    COVID-19 is disrupting business activities and global markets in unprecedented ways.  In response, the U.S. Department of Justice (DOJ) and Federal Trade Commission (FTC) have issued a variety of statements and implemented procedural changes regarding enforcement of antitrust laws and review of business mergers and acquisitions. 

    Businesses should be aware of the following recent actions by the DOJ and FTC.  Due to rapidly changing responses to the COVID-19 pandemic, businesses should also consult with their antitrust counsel to remain up to date on new developments and to identify appropriate strategies.  

    DOJ warns about price-fixing, bid-rigging, and market allocation schemes

    On March 9, 2020, DOJ issued a warning about its intention to investigate and hold accountable anyone violating antitrust laws with respect to the manufacturing, distribution, or sale of public health products such as face masks, sterile gloves, respirators, and diagnostics in connection with the COVID-19 pandemic.  Individuals or companies that engage in price-fixing, bid-rigging, or market allocation schemes could be criminally prosecuted.  To that end, DOJ also recently announced a Procurement Collusion Strike Force that will be on “high alert” for anticompetitive practices with respect to sales of such products to federal, state, and local government agencies. [1]

    DOJ implements temporary changes to civil merger investigation processes

    On March 17, 2020, DOJ announced that it adopted a series of temporary changes to its civil merger investigation processes while COVID-19 disruptions continue.  The temporary changes include the following:

    • the Antitrust Division is requesting an additional 30 days in timing agreements to complete review of transactions after parties involved in mergers comply with document requests, with the potential for revisiting timing agreements based on further developments;
    • the Antitrust Division will conduct meetings by phone or video conference if possible; and
    • all scheduled depositions are postponed and will be rescheduled using secure videoconferencing capabilities. [2]

    FTC issues COVID-19 guidance for Hart-Scott-Rodino (HSR) filings

    On March 13, 2020, the FTC’s Premerger Notification Office (PNO) suspended all hard copy and DVD submissions of HSR filings, and on March 17, 2020, the PNO and DOJ began accepting HSR filings through a temporary e-filing system.  The PNO also issued new guidance about the e-filing process on March 17, 2020.  Apart from providing guidance about the process for completing e-filing submissions, the PNO stated that review of HSR filings “will continue as normal,” even though it “will not be granting” early termination of the HSR waiting period. [3] The last grants of early termination occurred on March 13, 2020, and the PNO will not grant early termination for any other transactions while the temporary e-filing system is in place, even if parties to transactions completed HSR filings before March 13, 2020. 

    FTC review of investigations and litigations for timing modifications

    Apart from other changes in procedures announced by the FTC’s Bureau of Competition on March 16, 2020, the Bureau is conducting a “matter-by-matter review” of its investigations and litigations to identify appropriate modification of statutory or agreed-to timing.  The Bureau is reaching out to parties and their counsel to propose modifications and it is inviting parties and their counsel to propose modified time periods.  The Bureau is seeking “a flexible and reasonable approach,” but the Bureau warns that it “will take affirmative action” if an unmodified time period inhibits its ability to “address competitive concerns,” particularly because “virtually all” of the Bureau’s employees are working remotely and official travel is restricted. [4]


    1. US Dept. of Justice press release, “Justice Department Cautions Business Community Against Violating Antitrust Laws in the Manufacturing, Distribution, and Sale of Public Health Products” (Mar. 9, 2020), available at https://www.justice.gov/opa/pr/justice-department-cautions-business-community-against-violating-antitrust-laws-manufacturing. [Back to reference]
    2. US Dept. of Justice press release, “Justice Department Announces Antitrust Civil Process Changes for Pendency of COVID-19 Event” (Mar. 17, 2020), available at https://www.justice.gov/opa/pr/justice-department-announces-antitrust-civil-process-changes-pendency-covid-19-event. [Back to reference]
    3. U.S. Federal Trade Commission, “COVID-19 – Guidance for Filing Parties” (updated Mar. 17, 2020), available at https://www.ftc.gov/enforcement/premerger-notification-program/guidance-filing-parties. [Back to reference]
    4. Ian Connor, Bureau of Competition, “Changes in Bureau procedure during COVID-19 coronavirus pandemic” (Mar. 16, 2020), available at https://www.ftc.gov/news-events/blogs/competition-matters/2020/03/changes-bureau-procedure-during-covid-19-coronavirus. [Back to reference]

    Practices

    Mergers, Acquisitions, and Corporate Transactions Private Equity & Investment FundsSecurities & Capital MarketsGovernment Investigations & White Collar DefenseCongressional InvestigationsAntitrustSecurities & Governance Litigation

    Insights And Happenings

    • Alert

      The end of ACPERA?

      June 25, 2020
    • Alert

      New House committee on coronavirus may shift investigatory landscape for federal fund recipients

      May 1, 2020
    • Alert

      CMS announces new transparency rules for nursing facilities with coronavirus (COVID-19) cases

      April 22, 2020
    The foregoing has been prepared for the general information of clients and friends of the firm. It is not meant to provide legal advice with respect to any specific matter and should not be acted upon without professional counsel. If you have any questions or require any further information regarding these or other related matters, please contact your regular Nixon Peabody LLP representative. This material may be considered advertising under certain rules of professional conduct.

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • Cookie Preferences
    • Privacy Policy
    • Terms of Use
    • Accessibility Statement
    • Statement of Client Rights
    • Purchase Order Terms & Conditions
    • Nixon Peabody International LLC
    • PAL
    © 2025 Nixon Peabody. All rights reserved